Form 4 for EDSA Edesa Biotech, Inc.
Accepted 2022-03-14 00:00:00 ET · period of report 2022-03-11 · accession 0001654954-22-003095 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2022-03-14 | 2022-03-11 | EDSA | Nijhawan Pardeep | CEO, Dir, 10% | P - Purchase | $3.09 | +7,000 | 555.8K | +1% | +$21.7K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Shares | 2022-03-11 | P | A | 2,000 | $3.18 | 550,812 | D | — | — | |
| 2 | Common | Common Shares | 2022-03-11 | P | A | 5,000 | $3.06 | 555,812 | D | — | — |